Author:
Sarisozen Can,Salzano Giuseppina,Torchilin Vladimir P.
Abstract
AbstractIn the 1990s an unexpected gene-silencing phenomena in plants, the later called RNA interference (RNAi), perplexed scientists. Following the proof of activity in mammalian cells, small interfering RNAs (siRNAs) have quickly crept into biomedical research as a new powerful tool for the potential treatment of different human diseases based on altered gene expression. In the past decades, several promising data from ongoing clinical trials have been reported. However, despite surprising successes in many pre-clinical studies, concrete obstacles still need to be overcome to translate therapeutic siRNAs into clinical reality. Here, we provide an update on the recent advances of RNAi-based therapeutics and highlight novel synthetic platforms for the intracellular delivery of siRNAs.
Subject
Cellular and Molecular Neuroscience,General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference354 articles.
1. Confirming the RNAi - mediated mechanism of action of siRNA - based cancer therapeutics in mice;Judge;J Clin Invest,2009
2. approach for drug addiction therapy : gene silencing using delivery of gold nanorod - siRNA nanoplex in dopaminergic neurons;Bonoiu;Nanotechnology Proc Natl Acad Sci USA,2009
3. Enhanced chemotherapy efficacy by sequential delivery of siRNA and anticancer drugs using PEI - grafted graphene oxide;Zhang;Small,2011
4. Discovery and development of the rich oligonucleotide AS as a novel treatment for cancer;Bates;Exp Mol Pathol,1411
5. a highly efficient lipid - mediated DNA - transfection procedure;Felgner;Proc Natl Acad Sci USA,1987
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献